Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.7951
-0.1195 (-13.07%)
At close: Nov 16, 2026, 4:00 PM EST
0.8400
+0.0449 (5.65%)
Pre-market: Nov 17, 2026, 8:35 AM EST
Lineage Cell Therapeutics Market Cap
Lineage Cell Therapeutics has a market cap or net worth of $202.87 million as of November 16, 2026. It is the 20,276th most valuable company in the world and the 3,496th biggest in the United States. Its market cap has decreased by 53.15% in one year.
Market Cap
202.87M
Enterprise Value
159.73M
1-Year Change
-53.15%
Global Rank
Country Rank
#3,496 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Lineage Cell Therapeutics's market cap has increased from $147.40M to $202.87M, an increase of 37.63%. That is a compound annual growth rate of 1.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 202.87M | -47.25% |
| Dec 31, 2025 | 384.60M | 305.70% |
| Dec 31, 2024 | 94.80M | -50.29% |
| Dec 29, 2023 | 190.70M | -4.12% |
| Dec 30, 2022 | 198.90M | -51.84% |
| Dec 31, 2021 | 413.00M | 56.44% |
| Dec 31, 2020 | 264.00M | 98.05% |
| Dec 31, 2019 | 133.30M | 15.01% |
| Dec 31, 2018 | 115.90M | -57.51% |
| Dec 29, 2017 | 272.80M | -26.90% |
| Dec 30, 2016 | 373.20M | -4.09% |
| Dec 31, 2015 | 389.10M | 25.52% |
| Dec 31, 2014 | 310.00M | 28.15% |
| Dec 31, 2013 | 241.90M | 51.38% |
| Dec 31, 2012 | 159.80M | -45.26% |
| Dec 30, 2011 | 291.90M | -26.38% |
| Dec 31, 2010 | 396.50M | 181.41% |
| Dec 31, 2009 | 140.90M | 234.68% |
| Dec 31, 2008 | 42.10M | 347.87% |
| Dec 31, 2007 | 9.40M | 54.10% |
| Dec 29, 2006 | 6.10M | 10.91% |
| Dec 30, 2005 | 5.50M | -79.55% |
| Dec 31, 2004 | 26.90M | 43.09% |
| Dec 31, 2003 | 18.80M | -10.05% |
| Dec 31, 2002 | 20.90M | -60.79% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcturus Therapeutics Holdings | 253.35M |
| Cabaletta Bio | 252.39M |
| Faeth Therapeutics | 252.20M |
| Camp4 Therapeutics | 249.45M |
| Rocket Pharmaceuticals | 249.00M |
| Bright Minds Biosciences | 235.21M |
| Vanda Pharmaceuticals | 231.60M |
| Immuneering | 230.56M |